Press Releases

Press Releases

Samsung Biologics signs a Strategic Manufacturing Partnership with Roche

Samsung Biologics signs a Strategic Manufacturing Partnership with Roche
 

Seoul(Korea) Oct 22th, 2013 ? Samsung Biologics and F.Hoffmann-La Roche today announced that they have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche;s proprietary commercial biologics medicines at its two manufacturing facilities in Incheon, South Korea, of which one is currently under construction.

Terms of the agreement will not be disclosed, including financial terms and products to be manufactured.

For more informations, please enter the following address.
http://www.samsungvillage.com/blog/2013/10/samsung-biologics-signs-a-strategic-manufacturing-partnership-with-roche.html 

Samsung Biologics signs a Strategic Manufacturing Partnership with Roche
 

Seoul(Korea) Oct 22th, 2013 – Samsung Biologics and F.Hoffmann-La Roche today announced that they have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche;s proprietary commercial biologics medicines at its two manufacturing facilities in Incheon, South Korea, of which one is currently under construction.

Terms of the agreement will not be disclosed, including financial terms and products to be manufactured.

For more informations, please enter the following address.
http://www.samsungvillage.com/blog/2013/10/samsung-biologics-signs-a-strategic-manufacturing-partnership-with-roche.html 

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION